Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Centessa Pharmaceuticals plc ADR shares valued at $573,905 were sold by SAHA SAURABH on Aug 23 ’24. At $12.30 per share, SAHA SAURABH sold 46,651 shares. The insider’s holdings dropped to 776,924 shares worth approximately $11.37 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Weinhoff Gregory M sold 17,802 shares, netting a total of over 218,792 in proceeds. Following the sale of shares at $12.29 each, the insider now holds 223,369 shares.
Before that, Weinhoff Gregory M had sold 12,198 shares from its account. In a trade valued at $148,430, the Chief Business Officer traded Centessa Pharmaceuticals plc ADR shares for $12.17 each. Upon closing the transaction, the insider’s holdings decreased to 12,198 shares, worth approximately $3.53 million.
As published in their initiating research note from Oppenheimer on July 18, 2024, Centessa Pharmaceuticals plc ADR [CNTA] has been an Outperform and the price target has been revised to $14. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid November. As of October 26, 2023, Morgan Stanley has increased its “an Underweight” rating to a “an Equal-weight” for CNTA. Earlier on June 21, 2023, Evercore ISI initiated its rating. Their recommendation was “an Outperform” for CNTA stock.
Analyzing CNTA Stock Performance
During the last five days, there has been a surge of approximately 8.37%. Over the course of the year, Centessa Pharmaceuticals plc ADR shares have jumped approximately 83.79%. Shares of the company reached a 52-week high of $14.91 on 09/04/24 and a 52-week low of $6.65 on 01/11/24. A 50-day SMA is recorded $10.82, while a 200-day SMA reached $9.45. Nevertheless, trading volume fell to 0.97 million shares from 0.32 million shares the previous day.
Support And Resistance Levels for Centessa Pharmaceuticals plc ADR (CNTA)
According to the 24-hour chart, there is a support level at 13.62, which, if violated, would cause prices to drop to 12.60. In the upper region, resistance lies at 15.28. The next price resistance is at 15.92. RSI (Relative Strength Index) is 71.88 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.82, which suggests the price will decrease in the coming days. Percent R is at 9.33%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
